Benjamin Maughan, M.D., PharmD

No bio available.

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Bayer Oncology
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Peloton Therapeutis
    Date added:
    05/06/2022
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Lilly
    Date added:
    07/11/2023
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Sanofi
    Date added:
    07/11/2023
    Date updated:
    10/01/2024
    Relationship end date:
    04/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Telix
    Date added:
    05/22/2024
    Date updated:
    10/01/2024
    Relationship end date:
    05/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Xencor
    Date added:
    05/22/2024
    Date updated:
    10/01/2024
    Relationship end date:
    05/01/2025
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    NCCN
    Date added:
    05/22/2024
    Date updated:
    10/01/2024
    Relationship end date:
    05/01/2025

Pages

Return to BTF's 2024 Updates on Hematology and Oncology, El Paso